Literature DB >> 21179892

Hemoglobin depletion from plasma: considerations for proteomic discovery in sickle cell disease and other hemolytic processes.

Lisa M Williams1, Zongming Fu, Pratima Dulloor, Timothy Yen, Emily Barron-Casella, William Savage, Jennifer E Van Eyk, James F Casella, Allen Everett.   

Abstract

PURPOSE: Hemoglobin (Hb) depletion with nickel affinity chromatography has been shown to increase the number of proteins identified in proteomic studies of erythrocytes, but limited data exist on the application of this technique in depletion of Hb from plasma or serum required for clinical biomarker studies. The aim of this study was to explore the potential of using nickel-beads for Hb depletion of plasma. EXPERIMENTAL
DESIGN: Nickelnitrilotriacetic acid (Ni–NTA) affinity chromatography was used to deplete Hb from hemolyzed plasma samples obtained from children with sickle cell disease (SCD, n=7) and normal human plasma (n=4). Ni–NTA-bound proteins were analyzed by one-dimensional GE, followed by in-gel digestion for characterization using an LTQ-Orbitrap hybrid mass spectrometer. In addition, the loss of two non-Hb-related plasma proteins, thrombospondin1 and L-selectin, by Ni–NTA was determined by ELISA (SCD n=6, non-SCD controls n=2).
RESULTS: Ni–NTA resulted in an average 60% decrease in plasma protein concentration, which was not hemolysis dependent. Specifically, Hb (7 peptides) and the top three proteins, -2-macroglobulin (75 peptides), apolipoprotein B-100 (73 peptides), and albumin (42 peptides) were Ni–NTA bound. In addition, using an ELISA assay two non-Hb-associated plasma proteins thrombospondin1 and L-selectin were decreased by Ni-NTA. CONCLUSIONS AND CLINICAL RELEVANCE: Hb depletion with Ni–NTA is effective for Hb removal but is not specific. There is a potential for deleterious depletion of potential biomarkers that may limit the applicability of this method. Consideration of alternate methods of Hb depletion for clinical proteomics may be warranted.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21179892      PMCID: PMC4364410          DOI: 10.1002/prca.201000054

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN: 1862-8346            Impact factor:   3.494


  18 in total

1.  Comparative study of three proteomic quantitative methods, DIGE, cICAT, and iTRAQ, using 2D gel- or LC-MALDI TOF/TOF.

Authors:  Wells W Wu; Guanghui Wang; Seung Joon Baek; Rong-Fong Shen
Journal:  J Proteome Res       Date:  2006-03       Impact factor: 4.466

2.  Enhanced detection of low abundance human plasma proteins using a tandem IgY12-SuperMix immunoaffinity separation strategy.

Authors:  Wei-Jun Qian; David T Kaleta; Brianne O Petritis; Hongliang Jiang; Tao Liu; Xu Zhang; Heather M Mottaz; Susan M Varnum; David G Camp; Lei Huang; Xiangming Fang; Wei-Wei Zhang; Richard D Smith
Journal:  Mol Cell Proteomics       Date:  2008-07-15       Impact factor: 5.911

3.  Identification of a nickel(II) binding site on hemoglobin which confers susceptibility to oxidative deamination and intramolecular cross-linking.

Authors:  J Levine; M Weickert; M Pagratis; J Etter; A Mathews; T Fattor; J Lippincott; I Apostol
Journal:  J Biol Chem       Date:  1998-05-22       Impact factor: 5.157

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide-mediated vascular smooth muscle relaxation.

Authors:  Jeff S Isenberg; Fuminori Hyodo; Ken-Ichiro Matsumoto; Martin J Romeo; Mones Abu-Asab; Maria Tsokos; Periannan Kuppusamy; David A Wink; Murali C Krishna; David D Roberts
Journal:  Blood       Date:  2006-11-02       Impact factor: 22.113

6.  Thrombospondin mediates adherence of CD36+ sickle reticulocytes to endothelial cells.

Authors:  K Sugihara; T Sugihara; N Mohandas; R P Hebbel
Journal:  Blood       Date:  1992-11-15       Impact factor: 22.113

7.  Immobilized metal ion affinity adsorption and immobilized metal ion affinity chromatography of biomaterials. Serum protein affinities for gel-immobilized iron and nickel ions.

Authors:  J Porath; B Olin
Journal:  Biochemistry       Date:  1983-03-29       Impact factor: 3.162

8.  A network model to predict the risk of death in sickle cell disease.

Authors:  Paola Sebastiani; Vikki G Nolan; Clinton T Baldwin; Maria M Abad-Grau; Ling Wang; Adeboye H Adewoye; Lillian C McMahon; Lindsay A Farrer; James G Taylor; Gregory J Kato; Mark T Gladwin; Martin H Steinberg
Journal:  Blood       Date:  2007-06-28       Impact factor: 22.113

9.  Thrombospondins function as regulators of angiogenesis.

Authors:  Paul Bornstein
Journal:  J Cell Commun Signal       Date:  2009-10-02       Impact factor: 5.782

10.  Neutrophils roll on adherent neutrophils bound to cytokine-induced endothelial cells via L-selectin on the rolling cells.

Authors:  R F Bargatze; S Kurk; E C Butcher; M A Jutila
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

View more
  3 in total

1.  Maximizing peptide identification events in proteomic workflows using data-dependent acquisition (DDA).

Authors:  Nicholas W Bateman; Scott P Goulding; Nicholas J Shulman; Avinash K Gadok; Karen K Szumlinski; Michael J MacCoss; Christine C Wu
Journal:  Mol Cell Proteomics       Date:  2013-07-02       Impact factor: 5.911

2.  Comparison of the RNA Content of Extracellular Vesicles Derived from Paracoccidioides brasiliensis and Paracoccidioides lutzii.

Authors:  Roberta Peres da Silva; Larissa G V Longo; Julia P C da Cunha; Tiago J P Sobreira; Marcio L Rodrigues; Helisson Faoro; Samuel Goldenberg; Lysangela R Alves; Rosana Puccia
Journal:  Cells       Date:  2019-07-23       Impact factor: 6.600

3.  Proteomic discovery in sickle cell disease: Elevated neurogranin levels in children with sickle cell disease.

Authors:  Eboni I Lance; Lisa M Faulcon; Zongming Fu; Jun Yang; Donna Whyte-Stewart; John J Strouse; Emily Barron-Casella; Kimberly Jones; Jennifer E Van Eyk; James F Casella; Allen D Everett
Journal:  Proteomics Clin Appl       Date:  2021-05-24       Impact factor: 3.603

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.